Tuesday, May 12, 2020 11:59:31 AM
By now many might know I am a former investment Pro. I taught my clients. They became more professional than most of the Investment so called Pros of the 70s, 80, and 1990s.
When I was asked will XYZ go up or down, I replied Yes, but not right away. This simple sentence says it all. Recall in January when I informed an unprofessional author of the statement; CYDY will never 1$ again? I took that person to school. It appears that the word NEVER is never correct.
SO, will CYDY cross 100$ in a year? Better question; do I write predictions for fun or do I think about it.
Answer; when CYDY receives the FDA Approval all bets should be removed from the table.
Meaning? If a shareholder was thinking about selling some or all shares they are thinking about creating a mistake of a lifetime. At that point Leronlimab could and as a read the Pandemic news it will explode. I can paint a picture that 500$ is possible. 100$ possible. 20$ a slam dunk.
Now CYDY switches from its current 100% Story Stock status (a company with a great to fantastic story with HIV, Cancer, and FLU) to a 30% fundamental stock (a company influenced the sales and earnings) and a 70% Story stock; (HIV and CANCER)
as an investment Pro I seldom advised purchase of Story Stocks. I had one gigantic hit on a ten year hold.
20 to 500 possible. If everyone is surprised and we do 5 billion in revs; very likely.
20 to 100 likely. If we do 1 billion in revs 20 is easy and 100 possible. That COULD be 100 X 1$ earnings = 100$ share price. (PE Ratio)
20 to 30$ easy.
Recent CYDY News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:55 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:01:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 10:15:19 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM